Skip Navigation


Europace Advance Access originally published online on April 7, 2007
Europace 2007 9(6):401-406; doi:10.1093/europace/eum031
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
9/6/401    most recent
eum031v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by De Sisti, A.
Right arrow Articles by Frank, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Sisti, A.
Right arrow Articles by Frank, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2007. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org


CRYOABLATION

Transvenous cryo-ablation of the slow pathway for the treatment of atrioventricular nodal re-entrant tachycardia: a single-centre initial experience study

A. De Sisti*, J. Tonet, N. Barakett, J. Lacotte, J.F. Leclercq and R. Frank

Rhythmology Unit, Cardiology Institute, Pitie-Salpetriere Hospital, Paris 75015, France

Aims Within the last several years, transvenous cryo-ablation has become an alternative method to perform ablation of the slow-pathway. This study evaluated the acute and long-term safety and effectiveness of atrio-ventricular nodal re-entrant tachycardia (AVNRT) cryo-ablation.

Methods and results The first 69 consecutive patients with AVNRT (60 slow–fast, 4 fast–slow, and 5 slow–slow) who underwent slow-pathway cryo-ablation were included. Mean age was 37 ± 15, body weight 68 ± 14 kg, symptom duration 125 ± 104 months, and number of ineffective antiarrhythmic (AA) drugs 1.8 ± 1.4. A 7 Fr cryo-catheter (Cryocath®) was used, with initially 4-mm-tip and later with 6-mm-tip electrode. Cryo-mapping (n = 7.9 ± 8.4 per pt) was performed at the temperature of –30°C to test the effect on the target ablation site. Successful cryo-mapping was defined as abolition of nodal conduction jump or AV nodal refractory period prolongation. Cryo-ablation (n = 5.1 ± 4.9 per pt) was then applied by freezing to –75°C for 4 min in duration if no AV-block occurred. Acute procedural success (defined as AVNRT non-inducibility) after the first cryo-ablation attempt was achieved in 60/69 patients (87%). During cryo-ablation, inadvertent transient AV-block was encountered in 14 patients (five I AV-block and nine II–III AV-block). A mid-septal target site was the only variable correlated with inadvertent AV-block occurrence during cryo-ablation (P < 0.02). Long-term clinical success after cryo-ablation was globally achieved in 56/66 (85%) with a mean follow-up of 18 ± 9 months (3 pts dropped-out). After the first procedure, 41/66 (62%) had no relapse, eight had a dramatic reduction in AVNRT duration-frequency and considered themselves cured, and five needed previously ineffective AA (with no relapse in three, drastic reduction in AVNRT duration-frequency in two). The five last patients needed one or more procedures, after which one had no recurrence and one had reduction in duration-frequency. Absence of recurrence after the first procedure was positively correlated with 6-mm-tip cryo-catheter use (<0.001) and negatively with acute procedural success (<0.001). At multivariate analysis, both were independently significant (<0.04 and <0.008, respectively). Long-term clinical success was correlated only with 6-mm-tip cryo-catheter use (<0.001).

Conclusions Slow pathway cryo-ablation is associated with an acute success but a higher recurrence rate. A 6-mm-tip cryo-catheter seems to assure during cryo-ablation a large acute and long-term success. AV-block seems non-guaranteed by a negative cryo-mapping, stressing on need of a careful surveillance. Nevertheless, the theoretical advantage of avoiding the risk of permanent AV-block when compared with radiofrequency needs larger series to be demonstrated.

Key Words: Atrioventricular node, Tachycardia, Mapping, Catheter ablation


* Corresponding author. Tel: +33 145409530; fax: +33 323243118. E-mail address: antoniodesisti{at}yahoo.fr

Manuscript submitted 28 December 2006. Accepted after revision 7 February 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
EuropaceHome page
A. Sandilands, P. Boreham, J. Pitts-Crick, and T. Cripps
Impact of cryoablation catheter size on success rates in the treatment of atrioventricular nodal re-entry tachycardia in 160 patients with long-term follow-up
Europace, June 1, 2008; 10(6): 683 - 686.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
G.P. Kimman, T. Szili-Torok, and L. J. Jordaens
Tachyarrhythmias in Koch's triangle: to be burned out or to be cool?
Europace, October 1, 2007; 9(10): 906 - 908.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.